Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Preferred Stock Liabilities: 2012-2014

Historic Preferred Stock Liabilities for Avadel Pharmaceuticals (AVDL) over the last 1 years, with Dec 2014 value amounting to -$104.7 million.

  • Avadel Pharmaceuticals' Preferred Stock Liabilities fell 77.70% to -$104.7 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$104.7 million, marking a year-over-year decrease of 77.70%. This contributed to the annual value of -$104.7 million for FY2014, which is 77.70% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Preferred Stock Liabilities stood at -$104.7 million for Q4 2014, which was down 126,761.74% from $82,624 recorded in Q3 2014.
  • Avadel Pharmaceuticals' 5-year Preferred Stock Liabilities high stood at $63.1 million for Q1 2014, and its period low was -$104.7 million during Q4 2014.
  • Its 3-year average for Preferred Stock Liabilities is -$14.7 million, with a median of $34,906 in 2013.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Preferred Stock Liabilities crashed by 2,165.12% in 2013 and then soared by 180,791.54% in 2014.
  • Over the past 3 years, Avadel Pharmaceuticals' Preferred Stock Liabilities (Quarterly) stood at -$2.6 million in 2012, then tumbled by 2,165.12% to -$58.9 million in 2013, then tumbled by 77.70% to -$104.7 million in 2014.
  • Its last three reported values are -$104.7 million in Q4 2014, $82,624 for Q3 2014, and $75,139 during Q2 2014.